Omniscope

Omniscope is a biotechnology startup hailing from the United States and was founded in 2021. The company's slogan "Science is we all" encapsulates its mission to create the world's largest immune databank by leveraging high-resolution immune cell sequencing and artificial intelligence. Omniscope aims to utilize this databank to drive informed therapy and diagnostic development, ultimately aiming to significantly impact healthcare on a global scale. The company recently secured a substantial €550.00K grant investment on 01 February 2024 from the European Commission, highlighting the confidence and support it has garnered. Omniscope's multidisciplinary team is committed to expediting the translation of research into tangible human benefits, aligning with their overarching goal of making healthcare accessible to everyone, everywhere.